James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 100,000 shares at $13.58 ($1.4M) on 2022-06-16, disclosed to the SEC on 2022-06-21.
Open-market sale of $1.4M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.58 | 20,809 | $283K | 20.7% |
| 2 | $13.58 | 20,809 | $283K | 20.7% |
| 3 | $13.73 | 29,191 | $401K | 29.3% |
| 4 | $13.73 | 29,191 | $401K | 29.3% |
| Total | $13.67 avg | 100,000 | $1.4M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |